Caplin Point Laboratories Ltd.

NSE: CAPLIPOINT | BSE: 524742 | ISIN: INE475E01026 | Industry: Pharmaceuticals
| Falling Comet
1692.1000 -12.10 (-0.71%)
NSE Feb 20, 2026 15:31 PM
Volume: 43,265
 

1692.10
-0.71%
ICICI Direct
Caplin Steriles caters mainly to the US and other regulated markets. So far, it has developed and filed 52 ANDAs in the US on its own and with partners, with 42 approvals as on date. The Company is also working on a portfolio of 40+ simple and complex Injectable and Ophthalmic products,...
Number of FII/FPI investors decreased from 190 to 174 in Dec 2025 qtr
More from Caplin Point Laboratories Ltd.
Recommended